MedTrace Logo

Renin-Angiotensin System Inhibitors and COVID-19

NCT04331574 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-04-02

No results posted yet for this study

Summary

Multicentric non-profit observational study, in patients with COVID-19 hospitalized in Italy, conducted through a pseudonymised survey.

Conditions

Sponsors & Collaborators

  • Societa Italiana dell'Ipertensione Arteriosa

    lead OTHER

Principal Investigators

  • Guido Iaccarino, MD · Federico II University

  • Guido Grassi, MD · Inversity of Milan, BICOCCA

  • MariaLorenza Muiesan, MD · Università degli Studi di Brescia

  • Claudio Borghi, MD · University of Bologna

  • Claudio Ferri, MD · University of L'Aquila

  • MASSIMO VOLPE, MD · Univerity of Rome "La Sapienza"

  • Leonardo Sechi · University of Udine

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-10
Primary Completion
2020-04-10
Completion
2020-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04331574 on ClinicalTrials.gov